CSIMarket
 
Prothena Corporation Public Limited Company  (NASDAQ: PRTA)
 

Prothena Public Limited's Customers Performance

PRTA



 
PRTA's Source of Revenues During the corresponding time, Prothena Corporation Public Limited Company saw a revenue deteriorated by -77.15 % year on year, sequentially revenue fell by -98.02 %. While revenue at the Prothena Corporation Public Limited Company's corporate clients

List of PRTA Customers




for the same period Prothena Corporation Public Limited Company revnue deteriorated by -77.15 % year on year, sequentially revenue fell by -98.02 %.

List of PRTA Customers

Prothena Public Limited's Business Units
Collaboration    202.38 % of total Revenue
License    4955.45 % of total Revenue
Collaboration Program, Global, Prx019    99.01 % of total Revenue






Prothena Public Limited's Comment on Sales, Marketing and Customers



The company serves customers in the healthcare industry who bill federal healthcare programs for products. Applicable regulatory statutes and laws include the federal False Claims Act, the federal Anti-Kickback Statute, the U.S. federal Civil Monetary Penalties Law, the U.S. federal Physician Payments Sunshine Act (Open Payments Program), and the U.S. federal Health Insurance Portability and Accountability Act of 1996 (HIPAA). Market segments include manufacturers of drugs, devices, biologics, and medical supplies reimbursed under Medicare, Medicaid, or the Children’s Health Insurance Program. The Physician Payments Sunshine Act mandates reporting of payments and transfers of value to U.S.-licensed physicians, physician assistants, nurse practitioners, clinical nurse specialists, anesthesiologist assistants, certified registered nurse anesthetists, certified nurse midwives, and teaching hospitals. The company operates within the context of federal healthcare programs and third-party payors.





Prothena Public Limited’s Comment on Sales, Marketing and Customers


The company serves customers in the healthcare industry who bill federal healthcare programs for products. Applicable regulatory statutes and laws include the federal False Claims Act, the federal Anti-Kickback Statute, the U.S. federal Civil Monetary Penalties Law, the U.S. federal Physician Payments Sunshine Act (Open Payments Program), and the U.S. federal Health Insurance Portability and Accountability Act of 1996 (HIPAA). Market segments include manufacturers of drugs, devices, biologics, and medical supplies reimbursed under Medicare, Medicaid, or the Children’s Health Insurance Program. The Physician Payments Sunshine Act mandates reporting of payments and transfers of value to U.S.-licensed physicians, physician assistants, nurse practitioners, clinical nurse specialists, anesthesiologist assistants, certified registered nurse anesthetists, certified nurse midwives, and teaching hospitals. The company operates within the context of federal healthcare programs and third-party payors.








PRTA's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Prothena Corporation Public Limited Company 470.35 57.94 -151.18 67
SUBTOTAL 0.00 0.00 0.00 -

Sources: Prothena Corporation Public Limited Company’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Prothena Corporation Public Limited Company’s corporate clients.
For your research, we’ve provided 9 tables on Prothena Corporation Public Limited Company corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.